LINDSEY KETTINGER: Open Payments
NPI 1770836363 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$937 in 47 payments from 19 companies in 2025. Trend: 2023 $919 · 2024 $810 · 2025 $937
Food & beverage: $937
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $153 |
| ABBVIE INC. | 6 | $108 |
| Lilly USA, LLC | 4 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| Exact Sciences Corporation | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| ViiV Healthcare Company | 2 | $48 |
| Seqirus USA Inc | 2 | $41 |
| Gilead Sciences, Inc. | 2 | $37 |
Products named: MOUNJARO, TRINTELLIX, CAPLYTA, Rybelsus, Ozempic, VRAYLAR, The Cologuard Plus Collection Kit, APRETUDE.
Industry payments across SC — which companies pay providers there.
